BK
Whereas increased cardiac BK-(1-9) levels       may contribute to the reduction of cardiac hypertrophy, the reduction in plasma       Ang-(1-7) levels and increase in Ang II levels in plasma and tissues may       compromise the therapeutic effects of combined NEP/ACE inhibition.
Whereas increased cardiac  @SUBJECT$ -(1-9) levels       may contribute to the  @PREDICAT$  of  @OBJECT$ , the reduction in plasma       Ang-(1-7) levels and increase in Ang II levels in plasma and tissues may       compromise the therapeutic effects of combined NEP/ACE inhibition.